Connect Biopharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $16 | $48 | $0 | $1,912 |
Gross Profit | 48 | 1,728 | ||
EBITDA | -13,253 | -22,871 | ||
EBIT | -13,424 | -23,054 | ||
Net Income | -17,200 | -12,899 | -10,272 | -23,217 |
Net Change In Cash | 16 | 48 | 0 | 1,912 |
Free Cash Flow | -17,440 | -12,894 | -10,040 | -15,889 |
Cash | 37,845 | 40,632 | 47,709 | 78,232 |
Basic Shares | 55,786 | 55,498 | 55,352 | 55,190 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $26,033 | $0 | $0 | $0 |
Gross Profit | 26,033 | -988 | -1,030 | |
EBITDA | -21,792 | -58,372 | -117,030 | -201,717 |
EBIT | -22,452 | -59,360 | -118,043 | -202,358 |
Net Income | -15,628 | -59,503 | -116,415 | -205,205 |
Net Change In Cash | 26,033 | 0 | 0 | 0 |
Free Cash Flow | -24,362 | -48,224 | -103,551 | -592,455 |
Cash | 78,232 | 105,663 | 80,371 | 268,024 |
Basic Shares | 55,213 | 55,067 | 55,044 | 52,272 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.31 |
2025-06-30 | -$0.23 |
2025-03-31 | -$0.19 |
2024-12-31 | -$0.42 |
